Literature DB >> 25078146

The altered mononuclear cell-derived cytokine response to glucose ingestion is not regulated by excess adiposity in polycystic ovary syndrome.

Frank González1, Chang Ling Sia, Marguerite K Shepard, Neal S Rote, Judi Minium.   

Abstract

CONTEXT: Excess adipose tissue is a source of inflammation. Polycystic ovary syndrome (PCOS) is a proinflammatory state and is often associated with excess abdominal adiposity (AA) alone and/or frank obesity.
OBJECTIVE: To determine the effect of glucose ingestion on cytokine release from mononuclear cells (MNC) in women with PCOS with and without excess AA and/or obesity.
DESIGN: A cross-sectional study.
SETTING: Academic medical center. PATIENTS: Twenty-three women with PCOS (seven normal weight with normal AA, eight normal weight with excess AA, eight obese) and 24 ovulatory controls (eight normal weight with normal AA, eight normal weight with excess AA, eight obese). INTERVENTION: Three-hour 75-g oral glucose tolerance test (OGTT). MAIN OUTCOME MEASURES: Body composition was measured by dual energy x-ray absorptiometry. Insulin sensitivity was derived from the OGTT (ISOGTT). TNFα, IL-6, and IL-1β release was measured in supernatants of cultured MNC isolated from blood samples drawn while fasting and 2 hours after glucose ingestion.
RESULTS: Insulin sensitivity was lower in obese subjects regardless of PCOS status and in normal-weight women with PCOS compared with normal-weight controls regardless of body composition status. In response to glucose ingestion, MNC-derived TNFα, IL-6, and IL-1β release decreased in both normal-weight control groups but failed to suppress in either normal-weight PCOS group and in obese women regardless of PCOS status. For the combined groups, the cytokine responses were negatively correlated with insulin sensitivity and positively correlated with abdominal fat and androgens.
CONCLUSIONS: Women with PCOS fail to suppress MNC-derived cytokine release in response to glucose ingestion, and this response is independent of excess adiposity. Nevertheless, a similar response is also a feature of obesity per se. Circulating MNC and excess adipose tissue are separate and distinct sources of inflammation in this population.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25078146      PMCID: PMC4223432          DOI: 10.1210/jc.2014-2046

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  39 in total

1.  Altered composition of high density lipoproteins in women with the polycystic ovary syndrome.

Authors:  M Rajkhowa; R H Neary; P Kumpatla; F L Game; P W Jones; M S Obhrai; R N Clayton
Journal:  J Clin Endocrinol Metab       Date:  1997-10       Impact factor: 5.958

2.  Adipocyte death defines macrophage localization and function in adipose tissue of obese mice and humans.

Authors:  Saverio Cinti; Grant Mitchell; Giorgio Barbatelli; Incoronata Murano; Enzo Ceresi; Emanuela Faloia; Shupei Wang; Melanie Fortier; Andrew S Greenberg; Martin S Obin
Journal:  J Lipid Res       Date:  2005-09-08       Impact factor: 5.922

3.  Palmitate activates the NF-kappaB transcription factor and induces IL-6 and TNFalpha expression in 3T3-L1 adipocytes.

Authors:  Kolapo M Ajuwon; Michel E Spurlock
Journal:  J Nutr       Date:  2005-08       Impact factor: 4.798

4.  Tumor necrosis factor-alpha stimulates proliferation of rat ovarian theca-interstitial cells.

Authors:  R Z Spaczynski; A Arici; A J Duleba
Journal:  Biol Reprod       Date:  1999-10       Impact factor: 4.285

5.  Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp.

Authors:  M Matsuda; R A DeFronzo
Journal:  Diabetes Care       Date:  1999-09       Impact factor: 19.112

6.  Hyperandrogenism exerts an anti-inflammatory effect in obese women with polycystic ovary syndrome.

Authors:  Frank González; Chang Ling Sia; Frank Z Stanczyk; Hilary E Blair; Michelle E Krupa
Journal:  Endocrine       Date:  2012-07-01       Impact factor: 3.633

7.  Insulin inhibits intranuclear nuclear factor kappaB and stimulates IkappaB in mononuclear cells in obese subjects: evidence for an anti-inflammatory effect?

Authors:  P Dandona; A Aljada; P Mohanty; H Ghanim; W Hamouda; E Assian; S Ahmad
Journal:  J Clin Endocrinol Metab       Date:  2001-07       Impact factor: 5.958

8.  Tumor necrosis factor-alpha in sera of obese patients: fall with weight loss.

Authors:  P Dandona; R Weinstock; K Thusu; E Abdel-Rahman; A Aljada; T Wadden
Journal:  J Clin Endocrinol Metab       Date:  1998-08       Impact factor: 5.958

9.  Circulating mononuclear cells in the obese are in a proinflammatory state.

Authors:  Husam Ghanim; Ahmad Aljada; Deborah Hofmeyer; Tufail Syed; Priya Mohanty; Paresh Dandona
Journal:  Circulation       Date:  2004-09-13       Impact factor: 29.690

10.  The independent effects of polycystic ovary syndrome and obesity on serum concentrations of gonadotrophins and sex steroids in premenopausal women.

Authors:  J Holte; T Bergh; G Gennarelli; L Wide
Journal:  Clin Endocrinol (Oxf)       Date:  1994-10       Impact factor: 3.478

View more
  14 in total

Review 1.  Chronic low-grade inflammation in polycystic ovary syndrome: is there a (patho)-physiological role for interleukin-1?

Authors:  Milica Popovic; Gideon Sartorius; Mirjam Christ-Crain
Journal:  Semin Immunopathol       Date:  2019-05-28       Impact factor: 9.623

2.  Lipid-induced mononuclear cell cytokine secretion in the development of metabolic aberration and androgen excess in polycystic ovary syndrome.

Authors:  F González; R V Considine; O A Abdelhadi; A J Acton
Journal:  Hum Reprod       Date:  2020-05-01       Impact factor: 6.918

3.  Oxidative Stress in Response to Saturated Fat Ingestion Is Linked to Insulin Resistance and Hyperandrogenism in Polycystic Ovary Syndrome.

Authors:  Frank González; Robert V Considine; Ola A Abdelhadi; Anthony J Acton
Journal:  J Clin Endocrinol Metab       Date:  2019-11-01       Impact factor: 5.958

4.  Saturated fat ingestion stimulates proatherogenic inflammation in polycystic ovary syndrome.

Authors:  Frank González; Robert V Considine; Ola A Abdelhadi; Jiaping Xue; Anthony J Acton
Journal:  Am J Physiol Endocrinol Metab       Date:  2021-10-11       Impact factor: 4.310

Review 5.  The Pathogenesis of Polycystic Ovary Syndrome (PCOS): The Hypothesis of PCOS as Functional Ovarian Hyperandrogenism Revisited.

Authors:  Robert L Rosenfield; David A Ehrmann
Journal:  Endocr Rev       Date:  2016-07-26       Impact factor: 19.871

6.  Inflammation Triggered by Saturated Fat Ingestion Is Linked to Insulin Resistance and Hyperandrogenism in Polycystic Ovary Syndrome.

Authors:  Frank González; Robert V Considine; Ola A Abdelhadi; Anthony J Acton
Journal:  J Clin Endocrinol Metab       Date:  2020-06-01       Impact factor: 5.958

7.  Saturated Fat Ingestion Promotes Lipopolysaccharide-Mediated Inflammation and Insulin Resistance in Polycystic Ovary Syndrome.

Authors:  Frank González; Robert V Considine; Ola A Abdelhadi; Anthony J Acton
Journal:  J Clin Endocrinol Metab       Date:  2019-03-01       Impact factor: 5.958

8.  Metabolomics reveals impaired maturation of HDL particles in adolescents with hyperinsulinaemic androgen excess.

Authors:  Sara Samino; Maria Vinaixa; Marta Díaz; Antoni Beltran; Miguel A Rodríguez; Roger Mallol; Mercedes Heras; Anna Cabre; Lorena Garcia; Nuria Canela; Francis de Zegher; Xavier Correig; Lourdes Ibáñez; Oscar Yanes
Journal:  Sci Rep       Date:  2015-06-23       Impact factor: 4.379

9.  High Serum Tumor Necrosis Factor-Alpha Levels in Women with Polycystic Ovary Syndrome: A Meta-Analysis.

Authors:  Lingling Gao; Yang Gu; Xianghua Yin
Journal:  PLoS One       Date:  2016-10-20       Impact factor: 3.240

10.  Adherence to the Mediterranean Diet, Dietary Patterns and Body Composition in Women with Polycystic Ovary Syndrome (PCOS).

Authors:  Luigi Barrea; Angela Arnone; Giuseppe Annunziata; Giovanna Muscogiuri; Daniela Laudisio; Ciro Salzano; Gabriella Pugliese; Annamaria Colao; Silvia Savastano
Journal:  Nutrients       Date:  2019-09-23       Impact factor: 5.717

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.